30567351|t|Low Sucrose, Omega-3 Enriched Diet Has Region-Specific Effects on Neuroinflammation and Synaptic Function Markers in a Mouse Model of Doxorubicin-Based Chemotherapy.
30567351|a|Chemotherapeutic agents such as doxorubicin may negatively affect long-term brain functioning in cancer survivors; neuroinflammation may play a causal role. Dietary approaches that reduce inflammation, such as lowering sucrose and increasing eicosapentaenoic acid plus docosahexaenoic acid (EPA + DHA), may attenuate chemotherapy-induced neuroinflammation and synaptic damage, thereby improving quality of life. Ovariectomized, C57BL/6 mice were assigned to a chemotherapy (9 mg/kg doxorubicin + 90 mg/kg cyclophosphamide) or vehicle two-injection regimen, with injections two and four weeks after starting diets. In Study 1, mice received low sucrose diets with EPA + DHA or No EPA + DHA for four to six weeks; tissues were collected four, seven, or 14 days after the second injection. Compared to vehicle, chemotherapy increased pro-inflammatory cytokine IL-1beta at day seven in the cortex and hippocampus, and reduced gene expression of synaptic marker Shank 3 at all timepoints in cortex, while EPA + DHA increased expression of Shank 3. In Study 2, high or low sucrose/EPA + DHA or No EPA + DHA diets were fed for five weeks; tissues were collected ten days after the second injection. Among chemotherapy-treated mice, brain DHA was higher with low sucrose feeding. Furthermore, low sucrose increased gene expression of Shank 1, while EPA + DHA increased expression of Shank 3 and reduced protein concentrations of pro-inflammatory markers IL-5, IL-6 and KC/GRO in the cortex, but not the hippocampus. Low sucrose, EPA + DHA diets may attenuate neuroinflammation and synaptic damage induced by doxorubicin-based chemotherapy in specific brain regions.
30567351	4	11	Sucrose	Chemical	MESH:D013395
30567351	66	83	Neuroinflammation	Disease	MESH:D000090862
30567351	119	124	Mouse	Species	10090
30567351	134	145	Doxorubicin	Chemical	MESH:D004317
30567351	198	209	doxorubicin	Chemical	MESH:D004317
30567351	263	269	cancer	Disease	MESH:D009369
30567351	281	298	neuroinflammation	Disease	MESH:D000090862
30567351	354	366	inflammation	Disease	MESH:D007249
30567351	385	392	sucrose	Chemical	MESH:D013395
30567351	408	429	eicosapentaenoic acid	Chemical	MESH:D015118
30567351	435	455	docosahexaenoic acid	Chemical	MESH:D004281
30567351	463	466	DHA	Chemical	MESH:C027493
30567351	504	521	neuroinflammation	Disease	MESH:D000090862
30567351	526	541	synaptic damage	Disease	MESH:D012183
30567351	594	601	C57BL/6	CellLine	CVCL:C0MU
30567351	602	606	mice	Species	10090
30567351	648	659	doxorubicin	Chemical	MESH:D004317
30567351	671	687	cyclophosphamide	Chemical	MESH:D003520
30567351	792	796	mice	Species	10090
30567351	810	817	sucrose	Chemical	MESH:D013395
30567351	835	838	DHA	Chemical	MESH:C027493
30567351	851	854	DHA	Chemical	MESH:C027493
30567351	1001	1013	inflammatory	Disease	MESH:D007249
30567351	1023	1031	IL-1beta	Gene	16176
30567351	1123	1130	Shank 3	Gene	58234
30567351	1172	1175	DHA	Chemical	MESH:C027493
30567351	1200	1207	Shank 3	Gene	58234
30567351	1233	1240	sucrose	Chemical	MESH:D013395
30567351	1247	1250	DHA	Chemical	MESH:C027493
30567351	1263	1266	DHA	Chemical	MESH:C027493
30567351	1385	1389	mice	Species	10090
30567351	1397	1400	DHA	Chemical	MESH:C027493
30567351	1421	1428	sucrose	Chemical	MESH:D013395
30567351	1455	1462	sucrose	Chemical	MESH:D013395
30567351	1492	1499	Shank 1	Gene	243961
30567351	1513	1516	DHA	Chemical	MESH:C027493
30567351	1541	1548	Shank 3	Gene	58234
30567351	1591	1603	inflammatory	Disease	MESH:D007249
30567351	1612	1616	IL-5	Gene	16191
30567351	1618	1622	IL-6	Gene	16193
30567351	1630	1633	GRO	Gene	14825
30567351	1678	1685	sucrose	Chemical	MESH:D013395
30567351	1693	1696	DHA	Chemical	MESH:C027493
30567351	1717	1734	neuroinflammation	Disease	MESH:D000090862
30567351	1739	1754	synaptic damage	Disease	MESH:D012183
30567351	1766	1777	doxorubicin	Chemical	MESH:D004317
30567351	Negative_Correlation	MESH:D013395	16193
30567351	Negative_Correlation	MESH:D013395	MESH:D012183
30567351	Association	MESH:D007249	16176
30567351	Negative_Correlation	MESH:D004281	MESH:D012183
30567351	Negative_Correlation	MESH:D015118	MESH:D007249
30567351	Negative_Correlation	MESH:D013395	14825
30567351	Positive_Correlation	MESH:D013395	58234
30567351	Negative_Correlation	MESH:D004281	MESH:D007249
30567351	Negative_Correlation	MESH:C027493	MESH:D012183
30567351	Negative_Correlation	MESH:D015118	MESH:D000090862
30567351	Positive_Correlation	MESH:D013395	243961
30567351	Negative_Correlation	MESH:D004317	MESH:D009369
30567351	Positive_Correlation	MESH:C027493	MESH:D013395
30567351	Negative_Correlation	MESH:D013395	MESH:D007249
30567351	Negative_Correlation	MESH:D004317	MESH:D013395
30567351	Comparison	MESH:D003520	MESH:D004317
30567351	Negative_Correlation	MESH:C027493	14825
30567351	Positive_Correlation	MESH:D004317	MESH:D012183
30567351	Negative_Correlation	MESH:C027493	16191
30567351	Negative_Correlation	MESH:C027493	16193
30567351	Negative_Correlation	MESH:D015118	MESH:D012183
30567351	Negative_Correlation	MESH:C027493	MESH:D004317
30567351	Negative_Correlation	MESH:D013395	MESH:D000090862
30567351	Association	MESH:D007249	16193
30567351	Association	MESH:D007249	14825
30567351	Association	MESH:D007249	16191
30567351	Negative_Correlation	MESH:C027493	MESH:D007249
30567351	Positive_Correlation	MESH:C027493	58234
30567351	Negative_Correlation	MESH:D013395	16191
30567351	Positive_Correlation	MESH:D004317	MESH:D000090862
30567351	Negative_Correlation	MESH:C027493	MESH:D000090862

